Abstract
The formation, inheritance, and removal of DNA methylation in the genome of mammalian cells is directly regulated by two families of enzymes–DNA methyltransferases (DNMTs) and Ten-Eleven Translocation proteins (TETs). DNMTs generate and maintain the inheritance of 5-methylcytosine (5mC), which is the substrate targeted by the TET enzymes for conversion to 5-hydroxymethylcytosine (5hmC) and its downstream oxidized derivatives. The activity of DNMT and TET is dependent on the availability of micronutrients and metabolite co-factors, including essential vitamins, amino acids, and trace metals, highlighting how DNA methylation levels can be directly enhanced, suppressed, or remodeled via metabolic and nutritional perturbations. Dynamic changes in DNA methylation are required during embryonic development, lineage specification, and maintenance of somatic cell function that can be fine-tuned based on the influence of essential micronutrients. As we age, DNA methylation and hydroxymethylation levels drift in patterning, leading to epigenetic dysregulation and genomic instability that underlies the formation and progression of multiple diseases including cancer. Understanding how DNA methylation can be regulated by micronutrients will have important implications for the maintenance of normal tissue function upon aging, and in the prevention and treatment of diseases for improved health and lifespan.
Introduction
DNA methylation in the form of 5-methylcytosine (5mC) can be found in ∼80% of CpGs in the genome and is primarily enriched in heterochromatin, working in positive feedback with silencing histone marks to maintain lineage identity (Lister et al., 2009). 5mC is conventionally known as a repressive epigenetic mark, controlling gene expression and chromatin organization to influence cellular development and differentiation (Guo et al., 2014). During development and in response to environmental stimuli, many 5mC marks are dynamic, including at shores of CpG islands, promoters, enhancers, and across gene bodies of differentially expressed genes (Deaton and Bird, 2011; Nguyen et al., 2022). DNA methyltransferases (DNMTs) catalyze the transfer of a methyl group to the 5’ position of cytosine residues to regulate de novo 5mC formation (DNMT3A and DNMT3B) independently of the cell cycle, or during DNA replication to ensure faithful DNA methylation inheritance (DNMT1) (Okano et al., 1999; Pradhan et al., 1999).
The Ten-eleven translocation (TET1-3) enzymes are considered to have an opposing role to the DNMTs due to their ability to oxidize 5mC to generate 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) (Tahiliani et al., 2009; Ito et al., 2010; He et al., 2011). TET proteins belong to a superfamily of dioxygenases that utilize Fe2+ and α-ketoglutarate (αKG) as essential cofactors (Lorsbach et al., 2003) [reviewed in (Lu et al., 2015a; Rasmussen and Helin, 2016; Wu and Zhang, 2017; Lio et al., 2020)]. The oxidized methylcytosines generated by TETs can be stable modifications in the genome or transient modifications that promote active or passive DNA demethylation (Tahiliani et al., 2009; Zhang et al., 2010; Bachman et al., 2014). DNMT1 preferentially recognizes hemi-methylated DNA to establish inheritance of methylation at palindromic CpG dinucleotides upon DNA replication (Bashtrykov et al., 2012) however, the inability of DNMT1 to recognize 5hmC causes a passive, cell-cycle dependent loss of DNA methylation (Otani et al., 2013). Unlike 5hmC that does not interfere with RNA or DNA polymerase extension, the iterative oxidation products 5fC and 5caC can slow RNA elongation (Wang L. et al., 2015), cause DNA polymerase pausing (Shibutani et al., 2014), and mimic a T:G mismatch leading to active removal and replacement with an unmethylated cytosine via base excision repair (BER) independently of DNA replication (Cortellino et al., 2011; He et al., 2011).
Essential micronutrients can directly or indirectly influence DNMT and/or TET activity that in turn impact DNA methylation levels (Figure 1). B vitamins can be regarded as pro-methylating micronutrients given their role in one-carbon metabolism that generates both nucleotides for DNA synthesis and the transfer of methyl groups required for the maintenance of DNA methylation (Tong et al., 2009; Lyon et al., 2020). The methyl group used in the formation of 5mC by DNMTs is derived from the coordinated effort of B2, B6, B9, B12, and the essential amino acid methionine. Together, these micronutrients regulate the folate and methionine cycles of one-carbon metabolism to generate S-adenosylmethionine (SAM), the sole methyl donor used by all methyltransferases to methylate proteins, RNA and DNA. TET catalytic activity is also dependent on metabolites and micronutrients whose abundance can be directly regulated by dietary supplementation. More recently it has been shown that vitamin C can act as a direct cofactor of TET enzymes to enhance 5hmC formation (Cimmino et al., 2017; Cimmino et al., 2018) by reducing ferric iron (Fe3+) to ferrous iron (Fe2+). Alterations in iron homeostasis may influence TET activity, as shown in the brain, liver, gut, lymphocytes, and cord blood cells (Jiang et al., 2021; Barks et al., 2022; Gao et al., 2022; Taeubert et al., 2022) and additional micronutrients, such as vitamin A, D, and E, have also been implicated as direct or indirect regulators of DNA methylation (Doig et al., 2013; Hore et al., 2016; Remely et al., 2017). Given that aberrant DNA methylation profiles are associated with aging (Sedivy et al., 2008; Salameh et al., 2020; He et al., 2021; Wilkinson et al., 2021; Lu et al., 2023) and that loss of function mutations in DNMT and TET enzymes are a hallmark of cancer (Delhommeau et al., 2009; Figueroa et al., 2010a; Li et al., 2011; Buscarlet et al., 2017; Ostrander et al., 2020), understanding the connection between DNA methylation maintenance and micronutrient availability may uncover liabilities associated with diseases upon aging (Patel et al., 2023) and reveal novel metabolic interventions that can be implemented to retain faithful DNA methylation patterns and function for disease prevention and longevity.
FIGURE 1
Micronutrient regulation of 5-methylcytosine formation and maintenance (pro-methylating micronutrients)
The role of several B vitamins in the direct regulation of one-carbon metabolism places these essential micronutrients as DNA methylation guardians of the epigenome. One-carbon metabolism is comprised of the folate and methionine cycles that coordinate both pyrimidine synthesis and the generation of S-adenosylmethionine (SAM), the sole methyl donor used by DNA methyltransferases to generate 5mC in the genome. The coordinated regulation of nucleotide synthesis and methylation by one-carbon metabolism ensures that DNA replication is coupled with DNA methylation inheritance (Ducker and Rabinowitz, 2017). A connection between the folate cycle and DNA methylation maintenance has been known for decades. Nutritional vitamin B9 or B12 deficiencies during gestation or polymorphisms in folate cycle enzymes of pregnant women are associated with neural tube defects (NTDs) (Smithells et al., 1976; Prevention of neural tube defects, 1991; Crider et al., 2011). The process of neurulation in embryos requires increased global methylation to promote neural tube fusion (Greene et al., 2011), and NTDs potentially form due to the lack of silencing of Notch1 and Sox2 (Alata Jimenez and Strobl-Mazzulla, 2022). Loss of serine hydroxymethyltransferase 1 (SHMT1) activity, which utilizes B6 as a cofactor, can impair neural tube closure (Beaudin et al., 2011; Beaudin et al., 2012). Moreover, polymorphisms that decrease the activity of methylenetetrahydrofolate reductase (MTHFR) (Prevention of neural tube defects, 1991), which depends on B2 as a cofactor, or methionine synthase (MS) that utilizes B12 as a cofactor (Tong et al., 2009; Guéant et al., 2020), and methionine synthase reductase that regenerates methylated B12 levels from its oxidized form have all been associated with NTDs (Botto and Yang, 2000; Imbard et al., 2013). One-carbon metabolism inhibitors such as the anti-folate methotrexate (MTX) that blocks the activity of dihydrofolate reductase (DHFR) promotes DNA hypomethylation in embryonic tissues and leads to NTDs (Greene et al., 2011; Wang X. et al., 2015). DNA methylation generated by DNMTs is required for closure of the neural tube, therefore as per one-carbon metabolic enzyme gene polymorphisms and B vitamin deficiencies, disruption of DNA methylation caused by Dnmt3b knockout, and DNMT or methylation cycle inhibitors also result in NTDs (Okano et al., 1999; Afman et al., 2005; Dunlevy et al., 2006).
The role of B vitamins in DNA methylation maintenance in other diseases and cell types have also been described. Clinical studies have shown that lower B9 intake leads to DNA hypomethylation in colonic tissue (Pufulete et al., 2003) and an increased risk of colorectal cancer (CRC) (Kim, 2007). A B9-deficient diet in post-menopausal women also causes DNA hypomethylation in lymphocytes (Jacob et al., 1998). Low dose therapy with MTX used in the treatment of rheumatoid arthritis demethylates the FOXP3 locus in developing regulatory T cells, resulting in their enhanced differentiation and suppression of inflammation (Cribbs et al., 2015; Rossetti et al., 2015). Furthermore, higher global DNA methylation in leukocytes is associated with decreased responsiveness to MTX in rheumatoid arthritis patients (Gosselt et al., 2019), indicating the importance of MTX’s hypomethylating activity.
Elevated levels of B9 or B12 supplementation are positively correlated with increased DNA methylation through increased methyl-donor availability. Combined B9 and B12 supplementation leads to increased DNA methylation in leukocytes (Kok DE. et al., 2015; Kok DEG. et al., 2015), and B12 supplementation alone increases DNA methylation in disease-free children (Yadav et al., 2018) and mouse models of depression and meningitis (de Queiroz et al., 2020; Trautmann et al., 2020). Supplementation with B9 increases sperm DNA methylation levels in a mouse model of the MTHFR polymorphism, and supplementation with B2 has also been shown to increase DNA methylation in peripheral leukocytes of healthy individuals or cardiovascular disease patients with an MTHFR polymorphism (Amenyah et al., 2020; Amenyah et al., 2021). Amongst the healthy population, there have been no reports of toxicity for excess B vitamin consumption; however, given that one-carbon metabolism promotes DNA methylation, caution may be warranted for high B vitamin supplementation in disease states driven by DNA hypermethylation phenotypes (Ehrlich, 2019).
Hydroxymethylation formation and DNA methylation removal via micronutrient mediated activation of the TET enzymes (pro-hydroxymethylation micronutrients)
Epigenetic plasticity, including the ability to remodel DNA methylation patterns in the genome, is integral to maintaining stem cell potency, lineage specification, and gene regulation in response to changes in the environment. The TET enzymes (TET1-3) are the only known mammalian DNA demethylases that can trigger the passive or active removal of 5mC in the genome (Tahiliani et al., 2009; Ito et al., 2010; He et al., 2011). TET1 is most highly expressed in embryonic stem cells, primordial germ cells, and neural tissues, whereas TET2 and TET3 are most highly expressed in stem, progenitor, and other differentiated adult cell populations (Lu et al., 2015a; Rasmussen and Helin, 2016; Wu and Zhang, 2017; Lio et al., 2020). While the TET enzymes all exhibit a conserved core C-terminal catalytic domain, they diverge in their N-terminal structure, in which TET2 lacks the CXXC DNA-binding motif found in TET1 and TET3 and therefore relies on protein-binding partners for its recruitment to chromatin (Ko et al., 2013; Rampal et al., 2014). TET activity is primarily associated with gene activation, given the enrichment of 5hmC within enhancers and gene bodies of actively expressed genes (Ficz et al., 2011; Rasmussen and Helin, 2016). The role of TET activity is perceived to oppose the gene silencing role of DNMTs; however, 5mC is an essential requirement for the generation of 5hmC and the iterative oxidized products 5fC and 5caC, thus DNA methylation and hydroxymethylation, as mediated by DNMTs and TETs, must work together to form and remove cytosine methylation in the DNA (Zhang et al., 2016; Gu et al., 2018; Lopez-Moyado et al., 2019; Chao et al., 2022). In addition to the 5mC DNA substrate, TET enzymes require Fe2+ and αKG as obligatory cofactors for their catalytic activity (Tahiliani et al., 2009). Perturbations in Fe2+ homeostasis can influence TET activity, where iron sufficiency is associated with increased TET activity and maintenance of 5hmC formation in cord blood, hepatocytes, enterocytes, and splenocytes (Jiang et al., 2021; Taeubert et al., 2022) whereas deficiencies in iron lead to reduced activity in the cerebellum of rats evidenced by decreased 5hmC levels and neurodevelopmental defects (Barks et al., 2022). However, in settings of excess iron and iron overloading, in which homeostatic responses may block cellular uptake of redox active iron (Conrad et al., 1963), TET enzymatic activity can also become impaired and promote pathogenic T cell expansion and systemic lupus erythematosus pathogenesis (Gao et al., 2022). These findings suggest that at a physiological level, the role of iron homeostasis and the balance between iron stores or redox active labile iron on TET activity requires further clarification.
Based on its role as a cofactor of αKG-dependent dioxygenases (αKGDDs), vitamin C was tested as an enhancer of TET activity. Acting as a targeted antioxidant, vitamin C can directly bind the C-terminal catalytic domain of Tet enzymes, promoting the reduction and recycling of Fe3+ to Fe2+ (Yin et al., 2013; Cimmino et al., 2017). Vitamin C has been shown to increase the levels of 5hmC, 5fC, and 5caC anywhere from 4 to 20-fold in a variety of contexts, including ESCs, fibroblasts and leukemia cells, within as little as 24 h (Wang et al., 2011; Minor et al., 2013; Yin et al., 2013; Cimmino et al., 2017; Mingay et al., 2018; Brabson et al., 2021). Increased 5hmC formation and DNA demethylation upon vitamin C treatment leads to improved reprogramming efficiency during iPSC formation, and enhanced pluripotency of ESC cultures (Hore et al., 2016) by reducing methylation normally gained at CpG islands (CGIs) of pluripotency genes during blastocyst to epiblast transition (Blaschke et al., 2013; Hu et al., 2014). Tissue specific studies of vitamin C treatment in lung, breast, bladder, and kidney cultures have also reported similar increases in 5hmC generation and DNA demethylation (Ge et al., 2018; Sant et al., 2018).
Interestingly, an algal homolog of the TET enzymes uses vitamin C directly instead of αKG as the primary cofactor for the generation of glucosyl-methylation marks in the genome to regulate photosynthesis (Xue et al., 2019). Vitamin C is a structural homolog of αKG, but unlike this TCA cycle intermediate, is an essential micronutrient for humans and therefore imparts a dependence for enhancing TET activity in the context of nutritional availability (Myllyla et al., 1978; Majamaa et al., 1986; Yin et al., 2013). One requirement for increased TET activity may be in the regulation of immune responses. In regulatory T (Treg) cells, vitamin C promotes DNA demethylation of a Foxp3 enhancer, promoting Treg differentiation and immunosuppressive function akin to the role of low-dose MTX in rheumatoid arthritis patients (Yue et al., 2021; Suga et al., 2023). Vitamin C also drives oxidized methylcytosine formation and DNA demethylation within the three enhancers of the Prdm1 locus that are silenced in naive B cells but require activation for plasma cell differentiation (Qi et al., 2020). The effect of vitamin C on lymphocyte differentiation, including Tregs and plasma cells, has been shown to be both Tet2 and Tet3 dependent, which are the most highly expressed of the three TET enzymes in hematopoietic cells (An et al., 2015; Brabson et al., 2023). Furthermore, vitamin C increases Th1-type chemokines and PD-L1 gene expression in a TET2-dependent manner resulting in enhanced sensitivity to anti-PD-1/PD-L1 therapy (Xu et al., 2019).
Deficiencies in vitamin C mimic loss-of-function mutations in TET2, which is the most frequently mutated of the TET enzymes in cancer and primarily in blood cell malignancy causing impaired DNA de-methylation. Aberrant DNA hypermethylation and/or vitamin C deficiency have both been reported in patients with hematological malignancies (Figueroa et al., 2010a; Figueroa et al., 2010b). Oral supplementation with vitamin C can raise plasma levels in patients with hematological malignancies, leading to an overall increase in the 5hmC/5mC ratio in circulating white blood cells (Gillberg et al., 2019) and a reduction in the proportion of hypermethylated loci caused by TET2 mutation (Taira et al., 2023). Normalization of low vitamin C serum levels via supplementation in murine models also leads to a restoration of 5hmC formation in hematopoietic cells that suppresses Tet2-deficient leukemia progression (Agathocleous et al., 2017). These studies provide proof of principle that altering vitamin C supplementation can have a powerful influence on the blood cell DNA methylome.
Recent studies have also implicated vitamin A as a regulator of TET activity and DNA demethylation. Vitamin A comprises multiple active metabolites termed retinoids that play an essential role in growth, development, and differentiation (Gudas, 2013). The active form of vitamin A, retinoic acid (RA), binds to retinoic acid and retinoid X receptors (RAR/RXR) in the nucleus that, in association with other transcriptional coactivators, localize to retinoic acid responsive elements (RAREs) in target genes to activate gene expression (Gudas, 2013; Hore et al., 2016; Coyle et al., 2018). Thymidine DNA glycosylase (TDG) promotes DNA demethylation by forming a complex with acetylated TET2 (Zhang et al., 2017), and RAR/RXR activation upon RA-signaling has been shown to recruit the histone acetyltransferase CBP, TET proteins, and TDG to trigger oxidized methylcytosine formation and DNA demethylation via BER at target gene loci (Leger et al., 2014; Hassan et al., 2017; Hassan et al., 2020). RA-signaling in this manner can initiate TET2-dependent DNA demethylation at the Hic1 locus, which is often hypermethylated in human cancers, such as colon, breast, and brain cancer (Hassan et al., 2020). RA-signaling in breast cancer cells also induces a RARB-TET2 complex, targeted to the promoters of genes involved in cellular differentiation, such as miR-200c (Wu et al., 2017). Defective RARB/TET2 signaling by loss of TET2 and/or deficient miR-200c expression is correlated with RA-resistant breast cancer cell growth and aggressiveness (Wu et al., 2017). RA treatment of human embryonic carcinoma stem cells has also described a TET2-dependent 5mC to 5hmC conversion in the HOXA gene cluster (Bocker et al., 2012). These studies collectively show that RAR, CBP, TET, and TDG enzymes play an interconnected role in the initiation of gene expression in response to RA-signaling. TET expression can also be directly up-regulated by RA-signaling, and alone or in combination with vitamin C, enhances 5hmC formation in ESCs (Hore et al., 2016). A conserved RARE identified in the first intron of the TET2 locus suggests that expression could be mediated via direct RAR binding (Hore et al., 2016). Thus, the ability to directly enhance TET expression and increase the catalytic rate of TET activity via combined treatment with vitamin A and vitamin C suggests that these micronutrients work together to activate gene expression via increased methylcytosine oxidation.
Indirect micronutrient regulation of DNA methylation
Other essential micronutrients have been reported to play an indirect role in the maintenance of DNA methylation via modulation of chromatin states and the regulation of DNA methyltransferase expression. Similar to RAR, the vitamin D receptor (VDR) forms a heterodimer with RXR at vitamin D responsive elements (VDREs) in the DNA (Doig et al., 2013; Krstic et al., 2022; Mirza et al., 2022). The active form of vitamin D, calcitriol [1,25(OH)2D3], when bound to VDR-RXR, triggers the recruitment of co-activators, including steroid receptor and p300/CBP (Fetahu et al., 2014). However, in the absence of its ligand, VDR-RXR is bound by co-repressors such as NCOR1 and SMRT that maintain repressive histone modifications at target loci (Doig et al., 2013; Fetahu et al., 2014). Vitamin D signaling may promote DNA hypomethylation via the downregulated expression of DNMT1 and DNMT3B (Jiao et al., 2019; Lai et al., 2020) in this matter. Likewise, vitamin E can influence the expression of DNMT1; both a decreased expression in liver cells and an increased level in colon cells have been reported (Remely et al., 2017; Zappe et al., 2018). Prostate cancer models treated with vitamin E exhibit decreased DNMT protein expression and reduced CpG methylation at target loci of genes involved in cellular redox homeostasis such as the Nrf2 promoter (Huang et al., 2012a). As oxidative stress is often correlated with increased global levels of 5mC (Garcia-Guede et al., 2020; Goncalves et al., 2021), it is possible that vitamin E can reduce DNA methylation indirectly due to its antioxidant activity (Ryan et al., 2010; Zappe et al., 2018).
Discussion and future directions
The balance of essential micronutrient intake and bioavailability has the potential to significantly alter DNA methylation and hydroxymethylation levels in the body (Figure 2). Research using datasets comprising thousands of samples to track alterations in DNA methylation associated with cellular development, differentiation, aging, and disease progression has led to the identification of DNA methylation biomarkers and epigenetic clocks that accurately estimate chronological age (Hannum et al., 2013; Horvath, 2013; Horvath and Raj, 2018), healthspan and lifespan (Levine et al., 2018; Lu et al., 2019; Lu et al., 2022), or the pace of aging (Belsky et al., 2022) in both humans and animal models. These same DNA methylation signatures are also being used to investigate the impact of lifestyle factors such as diet and nutritional status on disease risk and aging (Quach et al., 2017; Lu et al., 2019; Fitzgerald et al., 2021) that may reveal potential therapeutic interventions to slow aging phenotypes and age-related diseases, including cancer. Plant-based, Mediterranean, and methylation-supportive diets can rejuvenate DNA methylation aging signatures, decreasing chronological age predictions by 1–10 years in as little as 8 weeks of intervention (Gensous et al., 2020; Dwaraka et al., 2023; Fitzgerald et al., 2023). One study (Dwaraka et al., 2023) using blood samples from paired twins reported that a vegan diet compared to an omnivorous diet led to a significant decrease in overall epigenetic age acceleration measured using multiple DNA methylation biomarkers (Levine et al., 2018; Lu et al., 2019; Belsky et al., 2022; Lu et al., 2022) that correlated with fewer hypermethylated loci in the vegan diet, consistent with the notion that vegan diets contribute to a reduced intake and lower serum levels of B12 (Gilsing et al., 2010; Niklewicz et al., 2023) and methionine (McCarty et al., 2009; Sanderson et al., 2019; Allen and Locasale, 2021), two of the major regulators of methyl-donor (SAM) levels. However, no controlled studies have attempted to address how supplementation with specific micronutrients associates with epigenetic clocks and DNA methylation biomarkers of aging or disease.
FIGURE 2
An important caveat to consider when interpreting micronutrient influences on DNA methylation status using existing biomarkers is that the gold standard for measuring global DNA methylation in research and clinical diagnostics has historically relied on CpG hybridization array platforms using bisulfite-treated DNA. Unmethylated cytosines, 5fC, and 5caC, are converted to uracil upon bisulfite treatment, while both 5mC and 5hmC remain protected and measured as cytosine, rendering their contribution to DNA methylation signatures indistinguishable (Huang et al., 2010). DNA immunoprecipitation and base-resolution mapping of 5hmC, 5fC and 5caC in the mammalian genome have shown that most reside in a CpG context, enriched within gene bodies, low density CpG regions (CpG island shores), and at distal regulatory elements such as enhancers, where 5mC and 5hmC can be present in nearly equal representation (Williams et al., 2011; Wu et al., 2011; Huang et al., 2012b; Yu et al., 2012; Lu et al., 2015b; Xia et al., 2015). While the contribution of 5hmC, or the rarer modifications 5fC and 5caC, to the major DNA methylation biomarkers currently remains unknown, recent advances in base resolution mapping using alternate chemical and enzymatic conversion strategies (Huang et al., 2010; Booth et al., 2013; Schutsky et al., 2018) [reviewed in (Berney and McGouran, 2018)] should allow the contribution of nutritional interventions and micronutrient levels on DNMT vs. TET-mediated DNA methylation maintenance, epigenetic clocks, and other predictive disease biomarkers to be determined.
Statements
Author contributions
TL: Writing–original draft, Writing–review and editing. PL: Writing–original draft. JP: Writing–original draft. LC: Writing–review and editing.
Funding
The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This research was supported by the NIH (NCI 1R01CA282453-01), Leukemia & Lymphoma Society (7028-22), and Castaways Against Cancer Foundation.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AfmanL. A.BlomH. J.DrittijM. J.BrounsM. R.van StraatenH. W. (2005). Inhibition of transmethylation disturbs neurulation in chick embryos. Dev. Brain Res.158 (1-2), 59–65. 10.1016/j.devbrainres.2005.06.002
2
AgathocleousM.MeachamC. E.BurgessR. J.PiskounovaE.ZhaoZ.CraneG. M.et al (2017). Ascorbate regulates haematopoietic stem cell function and leukaemogenesis. Nature549 (7673), 476–481. 10.1038/nature23876
3
Alata JimenezN.Strobl-MazzullaP. H. (2022). Folate carrier deficiency drives differential methylation and enhanced cellular potency in the neural plate border. Front. Cell Dev. Biol.10, 834625. 10.3389/fcell.2022.834625
4
AllenA. E.LocasaleJ. W. (2021). Metabolomics: insights into plant-based diets. EMBO Mol. Med.13 (2), e13568. 10.15252/emmm.202013568
5
AmenyahS. D.McMahonA.WardM.DeaneJ.McNultyH.HughesC. F.et al (2020). Riboflavin supplementation alters global and gene-specific DNA methylation in adults with the MTHFR 677 TT genotype. Biochimie173, 17–26. 10.1016/j.biochi.2020.04.007
6
AmenyahS. D.WardM.McMahonA.DeaneJ.McNultyH.HughesC.et al (2021). DNA methylation of hypertension-related genes and effect of riboflavin supplementation in adults stratified by genotype for the MTHFR C677T polymorphism. Int. J. Cardiol.322, 233–239. 10.1016/j.ijcard.2020.09.011
7
AnJ.Gonzalez-AvalosE.ChawlaA.JeongM.Lopez-MoyadoI. F.LiW.et al (2015). Acute loss of TET function results in aggressive myeloid cancer in mice. Nat. Commun.6, 10071. 10.1038/ncomms10071
8
BachmanM.Uribe-LewisS.YangX.WilliamsM.MurrellA.BalasubramanianS. (2014). 5-Hydroxymethylcytosine is a predominantly stable DNA modification. Nat. Chem.6 (12), 1049–1055. 10.1038/nchem.2064
9
BarksA.BeesonM. M.HallstromT. C.GeorgieffM. K.TranP. V. (2022). Developmental iron deficiency dysregulates TET activity and DNA hydroxymethylation in the rat Hippocampus and cerebellum. Dev. Neurosci.44 (2), 80–90. 10.1159/000521704
10
BashtrykovP.JankeviciusG.SmarandacheA.JurkowskaR. Z.RagozinS.JeltschA. (2012). Specificity of Dnmt1 for methylation of hemimethylated CpG sites resides in its catalytic domain. Chem. Biol.19 (5), 572–578. 10.1016/j.chembiol.2012.03.010
11
BeaudinA. E.AbarinovE. V.MalyshevaO.PerryC. A.CaudillM.StoverP. J. (2012). Dietary folate, but not choline, modifies neural tube defect risk in Shmt1 knockout mice. Am. J. Clin. Nutr.95 (1), 109–114. 10.3945/ajcn.111.020305
12
BeaudinA. E.AbarinovE. V.NodenD. M.PerryC. A.ChuS.StablerS. P.et al (2011). Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. Am. J. Clin. Nutr.93 (4), 789–798. 10.3945/ajcn.110.002766
13
BelskyD. W.CaspiA.CorcoranD. L.SugdenK.PoultonR.ArseneaultL.et al (2022). DunedinPACE, a DNA methylation biomarker of the pace of aging. Elife11, e73420. 10.7554/elife.73420
14
BerneyM.McGouranJ. F. (2018). Methods for detection of cytosine and thymine modifications in DNA. Nat. Rev. Chem.2 (11), 332–348. 10.1038/s41570-018-0044-4
15
BlaschkeK.EbataK. T.KarimiM. M.Zepeda-MartinezJ. A.GoyalP.MahapatraS.et al (2013). Vitamin C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells. Nature500 (7461), 222–226. 10.1038/nature12362
16
BockerM. T.TuortoF.RaddatzG.MuschT.YangF. C.XuM.et al (2012). Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster. Nat. Commun.3, 818. 10.1038/ncomms1826
17
BoothM. J.OstT. W.BeraldiD.BellN. M.BrancoM. R.ReikW.et al (2013). Oxidative bisulfite sequencing of 5-methylcytosine and 5-hydroxymethylcytosine. Nat. Protoc.8 (10), 1841–1851. 10.1038/nprot.2013.115
18
BottoL. D.YangQ. (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am. J. Epidemiol.151 (9), 862–877. 10.1093/oxfordjournals.aje.a010290
19
BrabsonJ. P.LeesangT.MohammadS.CimminoL. (2021). Epigenetic regulation of genomic stability by vitamin C. Front. Genet.12, 675780. 10.3389/fgene.2021.675780
20
BrabsonJ. P.LeesangT.YapY. S.WangJ.LamM. Q.FangB.et al (2023). Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia. Cell Rep.42 (1), 112027. 10.1016/j.celrep.2023.112027
21
BuscarletM.ProvostS.ZadaY. F.BarhdadiA.BourgoinV.LepineG.et al (2017). DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. Blood130 (6), 753–762. 10.1182/blood-2017-04-777029
22
ChaoL.YangS.LiH.LongC.XiQ.ZuoY. (2022). Competitive binding of TET1 and DNMT3A/B cooperates the DNA methylation pattern in human embryonic stem cells. Biochimica Biophysica Acta (BBA) - Gene Regul. Mech.1865 (7), 194861. 10.1016/j.bbagrm.2022.194861
23
CimminoL.DolgalevI.WangY.YoshimiA.MartinG. H.WangJ.et al (2017). Restoration of TET2 function blocks aberrant self-renewal and leukemia progression. Cell170 (6), 1079–1095.e20. 10.1016/j.cell.2017.07.032
24
CimminoL.NeelB. G.AifantisI. (2018). Vitamin C in stem cell reprogramming and cancer. Trends Cell Biol.28 (9), 698–708. 10.1016/j.tcb.2018.04.001
25
ConradM. E.Jr.CrosbyW. H.MerrillB. (1963). Intestinal mucosal mechanisms controlling iron absorption. Blood22, 406–415. 10.1182/blood.v22.4.406.406
26
CortellinoS.XuJ.SannaiM.MooreR.CarettiE.CiglianoA.et al (2011). Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell146 (1), 67–79. 10.1016/j.cell.2011.06.020
27
CoyleK. M.DeanC. A.ThomasM. L.VidovicD.GiacomantonioC. A.HelyerL.et al (2018). DNA methylation predicts the response of triple-negative breast cancers to all-trans retinoic acid. Cancers (Basel)10 (11), 397. 10.3390/cancers10110397
28
CribbsA. P.KennedyA.PennH.AmjadiP.GreenP.ReadJ. E.et al (2015). Methotrexate restores regulatory T cell function through demethylation of the FoxP3 upstream enhancer in patients with rheumatoid arthritis. Arthritis & Rheumatology67 (5), 1182–1192. 10.1002/art.39031
29
CriderK. S.BaileyL. B.BerryR. J. (2011). Folic acid food fortification-its history, effect, concerns, and future directions. Nutrients3 (3), 370–384. 10.3390/nu3030370
30
DeatonA. M.BirdA. (2011). CpG islands and the regulation of transcription. Genes Dev.25 (10), 1010–1022. 10.1101/gad.2037511
31
DelhommeauF.DupontS.ValleV. D.JamesC.TrannoyS.MasseA.et al (2009). Mutation in TET2 in myeloid cancers. N. Engl. J. Med.360 (22), 2289–2301. 10.1056/nejmoa0810069
32
de QueirozK. B.Cavalcante-SilvaV.LopesF. L.RochaG. A.D'AlmeidaV.CoimbraR. S. (2020). Vitamin B(12) is neuroprotective in experimental pneumococcal meningitis through modulation of hippocampal DNA methylation. J. neuroinflammation17 (1), 96. 10.1186/s12974-020-01763-y
33
DoigC. L.SinghP. K.DhimanV. K.ThorneJ. L.BattagliaS.SobolewskiM.et al (2013). Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Carcinogenesis34 (2), 248–256. 10.1093/carcin/bgs331
34
DuckerG. S.RabinowitzJ. D. (2017). One-carbon metabolism in health and disease. Cell Metab.25 (1), 27–42. 10.1016/j.cmet.2016.08.009
35
DunlevyL. P.BurrenK. A.ChittyL. S.CoppA. J.GreeneN. D. (2006). Excess methionine suppresses the methylation cycle and inhibits neural tube closure in mouse embryos. FEBS Lett.580 (11), 2803–2807. 10.1016/j.febslet.2006.04.020
36
DwarakaV. B.AronicaL.Carreras-GalloN.RobinsonJ. L.HenningsT.LinA.et al (2023). Unveiling the epigenetic impact of vegan vs. Omnivorous diets on aging: insights from the twins nutrition study (TwiNS). medRxiv.
37
EhrlichM. (2019). DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics14 (12), 1141–1163. 10.1080/15592294.2019.1638701
38
FetahuI. S.HöbausJ.KállayE. (2014). Vitamin D and the epigenome. Front. Physiol.5, 164. 10.3389/fphys.2014.00164
39
FiczG.BrancoM. R.SeisenbergerS.SantosF.KruegerF.HoreT. A.et al (2011). Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature473 (7347), 398–402. 10.1038/nature10008
40
FigueroaM. E.Abdel-WahabO.LuC.WardP. S.PatelJ.ShihA.et al (2010b). Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell18 (6), 553–567. 10.1016/j.ccr.2010.11.015
41
FigueroaM. E.LugthartS.LiY.Erpelinck-VerschuerenC.DengX.ChristosP. J.et al (2010a). DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell17 (1), 13–27. 10.1016/j.ccr.2009.11.020
42
FitzgeraldK. N.CampbellT.MakaremS.HodgesR. (2023). Potential reversal of biological age in women following an 8-week methylation-supportive diet and lifestyle program: a case series. Aging (Albany NY)15 (6), 1833–1839. 10.18632/aging.204602
43
FitzgeraldK. N.HodgesR.HanesD.StackE.CheishviliD.SzyfM.et al (2021). Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial. Aging (Albany NY)13 (7), 9419–9432. 10.18632/aging.202913
44
GaoX.SongY.WuJ.LuS.MinX.LiuL.et al (2022). Iron-dependent epigenetic modulation promotes pathogenic T cell differentiation in lupus. J. Clin. investigation132 (9), e152345. 10.1172/jci152345
45
Garcia-GuedeA.VeraO.Ibanez-de-CaceresI. (2020). When oxidative stress meets epigenetics: implications in cancer development. Antioxidants (Basel)9 (6), 468. 10.3390/antiox9060468
46
GeG.PengD.XuZ.GuanB.XinZ.HeQ.et al (2018). Restoration of 5-hydroxymethylcytosine by ascorbate blocks kidney tumour growth. EMBO Rep.19 (8), e45401. 10.15252/embr.201745401
47
GensousN.GaragnaniP.SantoroA.GiulianiC.OstanR.FabbriC.et al (2020). One-year Mediterranean diet promotes epigenetic rejuvenation with country- and sex-specific effects: a pilot study from the NU-AGE project. Geroscience42 (2), 687–701. 10.1007/s11357-019-00149-0
48
GillbergL.OrskovA. D.NasifA.OhtaniH.MadajZ.HansenJ. W.et al (2019). Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: normalization of plasma vitamin C induces epigenetic changes. Clin. Epigenetics11 (1), 143. 10.1186/s13148-019-0739-5
49
GilsingA. M.CroweF. L.Lloyd-WrightZ.SandersT. A.ApplebyP. N.AllenN. E.et al (2010). Serum concentrations of vitamin B12 and folate in British male omnivores, vegetarians and vegans: results from a cross-sectional analysis of the EPIC-Oxford cohort study. Eur. J. Clin. Nutr.64 (9), 933–939. 10.1038/ejcn.2010.142
50
GoncalvesA. C.AlvesR.BaldeirasI.MarquesB.OliveirosB.PereiraA.et al (2021). DNA methylation is correlated with oxidative stress in myelodysplastic syndrome-relevance as complementary prognostic biomarkers. Cancers (Basel)13 (13), 3138. 10.3390/cancers13133138
51
GosseltH. R.van ZelstB. D.de RotteM.HazesJ. M. W.de JongeR.HeilS. G. (2019). Higher baseline global leukocyte DNA methylation is associated with MTX non-response in early RA patients. Arthritis Res. Ther.21 (1), 157. 10.1186/s13075-019-1936-5
52
GreeneN. D.StanierP.MooreG. E. (2011). The emerging role of epigenetic mechanisms in the etiology of neural tube defects. Epigenetics6 (7), 875–883. 10.4161/epi.6.7.16400
53
GuT.LinX.CullenS. M.LuoM.JeongM.EstecioM.et al (2018). DNMT3A and TET1 cooperate to regulate promoter epigenetic landscapes in mouse embryonic stem cells. Genome Biol.19 (1), 88. 10.1186/s13059-018-1464-7
54
GudasL. J. (2013). Retinoids induce stem cell differentiation via epigenetic changes. Seminars Cell & Dev. Biol.24 (10-12), 701–705. 10.1016/j.semcdb.2013.08.002
55
GuéantJ.-L.OussalahA.ZgheibR.SibliniY.HsuS. B.NamourF. (2020). Genetic, epigenetic and genomic mechanisms of methionine dependency of cancer and tumor-initiating cells: what could we learn from folate and methionine cycles. Biochimie173, 123–128. 10.1016/j.biochi.2020.03.015
56
GuoH.ZhuP.YanL.LiR.HuB.LianY.et al (2014). The DNA methylation landscape of human early embryos. Nature511 (7511), 606–610. 10.1038/nature13544
57
HannumG.GuinneyJ.ZhaoL.ZhangL.HughesG.SaddaS.et al (2013). Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol. Cell49 (2), 359–367. 10.1016/j.molcel.2012.10.016
58
HassanH. M.IsovicM.KolendowskiB.Bauer-MaisonN.OnaboteO.CecchiniM.et al (2020). Loss of thymine DNA glycosylase causes dysregulation of bile acid homeostasis and hepatocellular carcinoma. Cell Rep.31 (1), 107475. 10.1016/j.celrep.2020.03.039
59
HassanH. M.KolendowskiB.IsovicM.BoseK.DranseH. J.SampaioA. V.et al (2017). Regulation of active DNA demethylation through RAR-mediated recruitment of a TET/TDG complex. Cell Rep.19 (8), 1685–1697. 10.1016/j.celrep.2017.05.007
60
HeX.LiuJ.LiuB.ShiJ. (2021). The use of DNA methylation clock in aging research. Exp. Biol. Med. (Maywood)246 (4), 436–446. 10.1177/1535370220968802
61
HeY. F.LiB. Z.LiZ.LiuP.WangY.TangQ.et al (2011). Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science333 (6047), 1303–1307. 10.1126/science.1210944
62
HoreT. A.von MeyennF.RavichandranM.BachmanM.FiczG.OxleyD.et al (2016). Retinol and ascorbate drive erasure of epigenetic memory and enhance reprogramming to naive pluripotency by complementary mechanisms. Proc. Natl. Acad. Sci. U. S. A.113 (43), 12202–12207. 10.1073/pnas.1608679113
63
HorvathS. (2013). DNA methylation age of human tissues and cell types. Genome Biol.14 (10), R115. 10.1186/gb-2013-14-10-r115
64
HorvathS.RajK. (2018). DNA methylation-based biomarkers and the epigenetic clock theory of ageing. Nat. Rev. Genet.19 (6), 371–384. 10.1038/s41576-018-0004-3
65
HuX.ZhangL.MaoS. Q.LiZ.ChenJ.ZhangR. R.et al (2014). Tet and TDG mediate DNA demethylation essential for mesenchymal-to-epithelial transition in somatic cell reprogramming. Cell Stem Cell14 (4), 512–522. 10.1016/j.stem.2014.01.001
66
HuangY.KhorT. O.ShuL.SawC. L.WuT. Y.SuhN.et al (2012a). A gamma-tocopherol-rich mixture of tocopherols maintains Nrf2 expression in prostate tumors of TRAMP mice via epigenetic inhibition of CpG methylation. J. Nutr.142 (5), 818–823. 10.3945/jn.111.153114
67
HuangY.PastorW. A.ShenY.TahilianiM.LiuD. R.RaoA. (2010). The behaviour of 5-hydroxymethylcytosine in bisulfite sequencing. PLoS One5 (1), e8888. 10.1371/journal.pone.0008888
68
HuangY.PastorW. A.Zepeda-MartinezJ. A.RaoA. (2012b). The anti-CMS technique for genome-wide mapping of 5-hydroxymethylcytosine. Nat. Protoc.7 (10), 1897–1908. 10.1038/nprot.2012.103
69
ImbardA.BenoistJ.-F.BlomH. J. (2013). Neural tube defects, folic acid and methylation. Int. J. Environ. Res. Public Health10 (9), 4352–4389. 10.3390/ijerph10094352
70
ItoS.D'AlessioA. C.TaranovaO. V.HongK.SowersL. C.ZhangY. (2010). Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature466 (7310), 1129–1133. 10.1038/nature09303
71
JacobR. A.GretzD. M.TaylorP. C.JamesS. J.PogribnyI. P.MillerB. J.et al (1998). Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J. Nutr.128 (7), 1204–1212. 10.1093/jn/128.7.1204
72
JiangL.WangJ.WangK.WangH.WuQ.YangC.et al (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood138 (8), 689–705. 10.1182/blood.2020008986
73
JiaoX.WangL.WeiZ.LiuB.LiuX.YuX. (2019). Vitamin D deficiency during pregnancy affects the function of Th1/Th2 cells and methylation of IFN-gamma gene in offspring rats. Immunol. Lett.212, 98–105. 10.1016/j.imlet.2019.06.012
74
KimY. I. (2007). Folate and colorectal cancer: an evidence-based critical review. Mol. Nutr. food Res.51 (3), 267–292. 10.1002/mnfr.200600191
75
KoM.AnJ.BandukwalaH. S.ChavezL.AijoT.PastorW. A.et al (2013). Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature497 (7447), 122–126. 10.1038/nature12052
76
KokD. E.Dhonukshe-RuttenR. A.LuteC.HeilS. G.UitterlindenA. G.van der VeldeN.et al (2015a). The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects. Clin. Epigenetics7, 121. 10.1186/s13148-015-0154-5
77
KokD. E. G.Dhonukshe-RuttenR. A. M.LuteC.HeilS. G.UitterlindenA. G.van der VeldeN.et al (2015b). The effects of long-term daily folic acid and vitamin B12 supplementation on genome-wide DNA methylation in elderly subjects. Clin. Epigenetics7, 121. 10.1186/s13148-015-0154-5
78
KrsticN.BishopN.CurtisB.CooperC.HarveyN.LilycropK.et al (2022). Early life vitamin D depletion and mechanical loading determine methylation changes in the RUNX2, RXRA, and osterix promoters in mice. Genes Nutr.17 (1), 7. 10.1186/s12263-022-00711-0
79
LaiG. R.LeeY. F.YanS. J.TingH. J. (2020). Active vitamin D induces gene-specific hypomethylation in prostate cancer cells developing vitamin D resistance. Am. J. Physiology-Cell Physiology318 (5), C836–C847. 10.1152/ajpcell.00522.2019
80
LegerH.Smet-NoccaC.Attmane-ElakebA.Morley-FletcherS.BeneckeA. G.EilebrechtS. (2014). A TDG/CBP/RARα ternary complex mediates the retinoic acid-dependent expression of DNA methylation-sensitive genes. Genomics Proteomics Bioinforma.12 (1), 8–18. 10.1016/j.gpb.2013.11.001
81
LevineM. E.LuA. T.QuachA.ChenB. H.AssimesT. L.BandinelliS.et al (2018). An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY)10 (4), 573–591. 10.18632/aging.101414
82
LiZ.CaiX.CaiC. L.WangJ.ZhangW.PetersenB. E.et al (2011). Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood118 (17), 4509–4518. 10.1182/blood-2010-12-325241
83
LioC. W. J.YueX.Lopez-MoyadoI. F.TahilianiM.AravindL.RaoA. (2020). TET methylcytosine oxidases: new insights from a decade of research. J. Biosci.45, 21. 10.1007/s12038-019-9973-4
84
ListerR.PelizzolaM.DowenR. H.HawkinsR. D.HonG.Tonti-FilippiniJ.et al (2009). Human DNA methylomes at base resolution show widespread epigenomic differences. Nature462 (7271), 315–322. 10.1038/nature08514
85
Lopez-MoyadoI. F.TsagaratouA.YuitaH.SeoH.DelatteB.HeinzS.et al (2019). Paradoxical association of TET loss of function with genome-wide DNA hypomethylation. Proc. Natl. Acad. Sci. U. S. A.116 (34), 16933–16942. 10.1073/pnas.1903059116
86
LorsbachR. B.MooreJ.MathewS.RaimondiS. C.MukatiraS. T.DowningJ. R. (2003). TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia17 (3), 637–641. 10.1038/sj.leu.2402834
87
LuA. T.BinderA. M.ZhangJ.YanQ.ReinerA. P.CoxS. R.et al (2022). DNA methylation GrimAge version 2. Aging (Albany NY)14 (23), 9484–9549. 10.18632/aging.204434
88
LuA. T.FeiZ.HaghaniA.RobeckT. R.ZollerJ. A.LiC. Z.et al (2023). Universal DNA methylation age across mammalian tissues. Nat. Aging3 (9), 1144–1166. 10.1038/s43587-023-00462-6
89
LuA. T.QuachA.WilsonJ. G.ReinerA. P.AvivA.RajK.et al (2019). DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging (Albany NY)11 (2), 303–327. 10.18632/aging.101684
90
LuX.HanD.ZhaoB. S.SongC. X.ZhangL. S.DoreL. C.et al (2015b). Base-resolution maps of 5-formylcytosine and 5-carboxylcytosine reveal genome-wide DNA demethylation dynamics. Cell Res.25 (3), 386–389. 10.1038/cr.2015.5
91
LuX.ZhaoB. S.HeC. (2015a). TET family proteins: oxidation activity, interacting molecules, and functions in diseases. Chem. Rev.115 (6), 2225–2239. 10.1021/cr500470n
92
LyonP.StrippoliV.FangB.CimminoL. (2020). B vitamins and one-carbon metabolism: implications in human health and disease. Nutrients12 (9), 2867. 10.3390/nu12092867
93
MajamaaK.GunzlerV.Hanauske-AbelH. M.MyllylaR.KivirikkoK. I. (1986). Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. J. Biol. Chem.261 (17), 7819–7823. 10.1016/s0021-9258(19)57475-0
94
McCartyM. F.Barroso-ArandaJ.ContrerasF. (2009). The low-methionine content of vegan diets may make methionine restriction feasible as a life extension strategy. Med. Hypotheses72 (2), 125–128. 10.1016/j.mehy.2008.07.044
95
MingayM.ChaturvediA.BilenkyM.CaoQ.JacksonL.HuiT.et al (2018). Vitamin C-induced epigenomic remodelling in IDH1 mutant acute myeloid leukaemia. Leukemia32 (1), 11–20. 10.1038/leu.2017.171
96
MinorE. A.CourtB. L.YoungJ. I.WangG. (2013). Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine. J. Biol. Chem.288 (19), 13669–13674. 10.1074/jbc.c113.464800
97
MirzaI.MohamedA.DeenH.BalajiS.ElsabbahiD.MunasserA.et al (2022). Obesity-associated vitamin D deficiency correlates with adipose tissue DNA hypomethylation, inflammation, and vascular dysfunction. Int. J. Mol. Sci.23 (22), 14377. 10.3390/ijms232214377
98
MyllylaR.Kuutti-SavolainenE. R.KivirikkoK. I. (1978). The role of ascorbate in the prolyl hydroxylase reaction. Biochem. Biophysical Res. Commun.83 (2), 441–448. 10.1016/0006-291x(78)91010-0
99
NguyenT. T.TranT. A.LeN. Q.PhamD. M.OuY. Y. (2022). An extensive examination of discovering 5-methylcytosine sites in genome-wide DNA promoters using machine learning based approaches. IEEE/ACM Trans. Comput. Biol. Bioinforma.19 (1), 87–94. 10.1109/tcbb.2021.3082184
100
NiklewiczA.SmithA. D.SmithA.HolzerA.KleinA.McCaddonA.et al (2023). The importance of vitamin B(12) for individuals choosing plant-based diets. Eur. J. Nutr.62 (3), 1551–1559. 10.1007/s00394-022-03025-4
101
OkanoM.BellD. W.HaberD. A.LiE. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell99 (3), 247–257. 10.1016/s0092-8674(00)81656-6
102
OstranderE. L.KramerA. C.MallaneyC.CelikH.KohW. K.FairchildJ.et al (2020). Divergent effects of Dnmt3a and Tet2 mutations on hematopoietic progenitor cell fitness. Stem Cell Rep.14 (4), 551–560. 10.1016/j.stemcr.2020.02.011
103
OtaniJ.AritaK.KatoT.KinoshitaM.KimuraH.SuetakeI.et al (2013). Structural basis of the versatile DNA recognition ability of the methyl-CpG binding domain of methyl-CpG binding domain protein 4. J. Biol. Chem.288 (9), 6351–6362. 10.1074/jbc.m112.431098
104
PatelP.SelvarajuV.BabuJ. R.GeethaT. (2023). Association of the DNA methylation of obesity-related genes with the dietary nutrient intake in children. Nutrients15 (13), 2840. 10.3390/nu15132840
105
PradhanS.BacollaA.WellsR. D.RobertsR. J. (1999). Recombinant human DNA (Cytosine-5) methyltransferase. J. Biol. Chem.274 (46), 33002–33010. 10.1074/jbc.274.46.33002
106
Prevention of Neural Tube Defects. (1991). Prevention of neural tube defects: results of the medical research council vitamin study. MRC vitamin study research group. Lancet.338 (8760), 131–137. 10.1016/0140-6736(91)90133-A
107
PufuleteM.Al-GhnaniemR.LeatherA. J.ApplebyP.GoutS.TerryC.et al (2003). Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology124 (5), 1240–1248. 10.1016/s0016-5085(03)00279-8
108
QiT.SunM.ZhangC.ChenP.XiaoC.ChangX. (2020). Ascorbic acid promotes plasma cell differentiation through enhancing TET2/3-mediated DNA demethylation. Cell Rep.33 (9), 108452. 10.1016/j.celrep.2020.108452
109
QuachA.LevineM. E.TanakaT.LuA. T.ChenB. H.FerrucciL.et al (2017). Epigenetic clock analysis of diet, exercise, education, and lifestyle factors. Aging (Albany NY)9 (2), 419–446. 10.18632/aging.101168
110
RampalR.AlkalinA.MadzoJ.VasanthakumarA.PronierE.PatelJ.et al (2014). DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep.9 (5), 1841–1855. 10.1016/j.celrep.2014.11.004
111
RasmussenK. D.HelinK. (2016). Role of TET enzymes in DNA methylation, development, and cancer. Genes Dev.30 (7), 733–750. 10.1101/gad.276568.115
112
RemelyM.FerkF.SternederS.SetayeshT.KepcijaT.RothS.et al (2017). Vitamin E modifies high-fat diet-induced increase of DNA strand breaks, and changes in expression and DNA methylation of Dnmt1 and MLH1 in C57bl/6J male mice. Nutrients9 (6), 607. 10.3390/nu9060607
113
RossettiM.SpreaficoR.SaidinS.ChuaC.MoshrefM.LeongJ. Y.et al (2015). Ex vivo-expanded but not in vitro-induced human regulatory T cells are candidates for cell therapy in autoimmune diseases thanks to stable demethylation of the FOXP3 regulatory T cell-specific demethylated region. J. Immunol.194 (1), 113–124. 10.4049/jimmunol.1401145
114
RyanM. J.DudashH. J.DochertyM.GeronillaK. B.BakerB. A.HaffG. G.et al (2010). Vitamin E and C supplementation reduces oxidative stress, improves antioxidant enzymes and positive muscle work in chronically loaded muscles of aged rats. Exp. Gerontol.45 (11), 882–895. 10.1016/j.exger.2010.08.002
115
SalamehY.BejaouiY.El HajjN. (2020). DNA methylation biomarkers in aging and age-related diseases. Front. Genet.11, 171. 10.3389/fgene.2020.00171
116
SandersonS. M.GaoX.DaiZ.LocasaleJ. W. (2019). Methionine metabolism in health and cancer: a nexus of diet and precision medicine. Nat. Rev. Cancer19 (11), 625–637. 10.1038/s41568-019-0187-8
117
SantD. W.CamarenaV.MustafiS.LiY.WilkesZ.Van BoovenD.et al (2018). Ascorbate suppresses VEGF expression in retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci.59 (8), 3608–3618. 10.1167/iovs.18-24101
118
SchutskyE. K.DeNizioJ. E.HuP.LiuM. Y.NabelC. S.FabyanicE. B.et al (2018). Nondestructive, base-resolution sequencing of 5-hydroxymethylcytosine using a DNA deaminase. Nat. Biotechnol.36, 1083–1090. 10.1038/nbt.4204
119
SedivyJ. M.BanumathyG.AdamsP. D. (2008). Aging by epigenetics--a consequence of chromatin damage?Exp. Cell Res.314 (9), 1909–1917. 10.1016/j.yexcr.2008.02.023
120
ShibutaniT.ItoS.TodaM.KanaoR.CollinsL. B.ShibataM.et al (2014). Guanine- 5-carboxylcytosine base pairs mimic mismatches during DNA replication. Sci. Rep.4, 5220. 10.1038/srep05220
121
SmithellsR. W.SheppardS.SchorahC. J. (1976). Vitamin dificiencies and neural tube defects. Archives Dis. Child.51 (12), 944–950. 10.1136/adc.51.12.944
122
SugaK.SutoA.TanakaS.SugawaraY.KageyamaT.IshikawaJ.et al (2023). TAp63, a methotrexate target in CD4+ T cells, suppresses Foxp3 expression and exacerbates autoimmune arthritis. JCI Insight.8 (10), e164778. 10.1172/jci.insight.164778
123
TaeubertM. J.de Prado-BertP.GeurtsenM. L.MancanoG.VermeulenM. J.ReissI. K. M.et al (2022). Maternal iron status in early pregnancy and DNA methylation in offspring: an epigenome-wide meta-analysis. Clin. Epigenetics14 (1), 59. 10.1186/s13148-022-01276-w
124
TahilianiM.KohK. P.ShenY.PastorW. A.BandukwalaH.BrudnoY.et al (2009). Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science324 (5929), 930–935. 10.1126/science.1170116
125
TairaA.PalinK.KuosmanenA.ValimakiN.KuittinenO.KuisminO.et al (2023). Vitamin C boosts DNA demethylation in TET2 germline mutation carriers. Clin. Epigenetics15 (1), 7. 10.1186/s13148-022-01404-6
126
TongX.ZhaoF.ThompsonC. B. (2009). The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr. Opin. Genet. Dev.19 (1), 32–37. 10.1016/j.gde.2009.01.002
127
TrautmannC.BockA.UrbachA.HübnerC. A.EngmannO. (2020). Acute vitamin B12 supplementation evokes antidepressant response and alters Ntrk-2. Neuropharmacology171, 108112. 10.1016/j.neuropharm.2020.108112
128
WangL.ZhouY.XuL.XiaoR.LuX.ChenL.et al (2015a). Molecular basis for 5-carboxycytosine recognition by RNA polymerase II elongation complex. Nature523 (7562), 621–625. 10.1038/nature14482
129
WangT.ChenK.ZengX.YangJ.WuY.ShiX.et al (2011). The histone demethylases Jhdm1a/1b enhance somatic cell reprogramming in a vitamin-C-dependent manner. Cell Stem Cell9 (6), 575–587. 10.1016/j.stem.2011.10.005
130
WangX.GuanZ.ChenY.DongY.NiuY.WangJ.et al (2015b). Genomic DNA hypomethylation is associated with neural tube defects induced by methotrexate inhibition of folate metabolism. PloS one10 (3), e0121869. 10.1371/journal.pone.0121869
131
WilkinsonG. S.AdamsD. M.HaghaniA.LuA. T.ZollerJ.BreezeC. E.et al (2021). DNA methylation predicts age and provides insight into exceptional longevity of bats. Nat. Commun.12 (1), 1615. 10.1038/s41467-021-21900-2
132
WilliamsK.ChristensenJ.PedersenM. T.JohansenJ. V.CloosP. A.RappsilberJ.et al (2011). TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature473 (7347), 343–348. 10.1038/nature10066
133
WuH.D'AlessioA. C.ItoS.WangZ.CuiK.ZhaoK.et al (2011). Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev.25 (7), 679–684. 10.1101/gad.2036011
134
WuM. J.KimM. R.ChenY. S.YangJ. Y.ChangC. J. (2017). Retinoic acid directs breast cancer cell state changes through regulation of TET2-PKCζ pathway. Oncogene36 (22), 3193–3206. 10.1038/onc.2016.467
135
WuX.ZhangY. (2017). TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet.18 (9), 517–534. 10.1038/nrg.2017.33
136
XiaB.HanD.LuX.SunZ.ZhouA.YinQ.et al (2015). Bisulfite-free, base-resolution analysis of 5-formylcytosine at the genome scale. Nat. Methods12 (11), 1047–1050. 10.1038/nmeth.3569
137
XuY. P.LvL.LiuY.SmithM. D.LiW. C.TanX. M.et al (2019). Tumor suppressor TET2 promotes cancer immunity and immunotherapy efficacy. J. Clin. Investigation129 (10), 4316–4331. 10.1172/jci129317
138
XueJ. H.ChenG. D.HaoF.ChenH.FangZ.ChenF. F.et al (2019). A vitamin-C-derived DNA modification catalysed by an algal TET homologue. Nature569 (7757), 581–585. 10.1038/s41586-019-1160-0
139
YadavD. K.ShresthaS.LillycropK. A.JoglekarC. V.PanH.HolbrookJ. D.et al (2018). Vitamin B(12) supplementation influences methylation of genes associated with Type 2 diabetes and its intermediate traits. Epigenomics10 (1), 71–90. 10.2217/epi-2017-0102
140
YinR.MaoS. Q.ZhaoB.ChongZ.YangY.ZhaoC.et al (2013). Ascorbic acid enhances Tet-mediated 5-methylcytosine oxidation and promotes DNA demethylation in mammals. J. Am. Chem. Soc.135 (28), 10396–10403. 10.1021/ja4028346
141
YuM.HonG. C.SzulwachK. E.SongC. X.ZhangL.KimA.et al (2012). Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell149 (6), 1368–1380. 10.1016/j.cell.2012.04.027
142
YueX.Samaniego-CastruitaD.Gonzalez-AvalosE.LiX.BarwickB. G.RaoA. (2021). Whole-genome analysis of TET dioxygenase function in regulatory T cells. EMBO Rep.22 (8), e52716. 10.15252/embr.202152716
143
ZappeK.PointnerA.SwitzenyO. J.MagnetU.TomevaE.HellerJ.et al (2018). Counteraction of oxidative stress by vitamin E affects epigenetic regulation by increasing global methylation and gene expression of MLH1 and DNMT1 dose dependently in caco-2 cells. Oxidative Med. Cell. Longev.2018, 1–13. 10.1155/2018/3734250
144
ZhangH.ZhangX.ClarkE.MulcaheyM.HuangS.ShiY. G. (2010). TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res.20 (12), 1390–1393. 10.1038/cr.2010.156
145
ZhangX.SuJ.JeongM.KoM.HuangY.ParkH. J.et al (2016). DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells. Nat. Genet.48 (9), 1014–1023. 10.1038/ng.3610
146
ZhangY. W.WangZ.XieW.CaiY.XiaL.EaswaranH.et al (2017). Acetylation enhances TET2 function in protecting against abnormal DNA methylation during oxidative stress. Mol. Cell65 (2), 323–335. 10.1016/j.molcel.2016.12.013
Summary
Keywords
DNA methylation, Ten-eleven translocation (TET) enzymes, 5-hydroxymethylation, vitamin A, vitamin B, vitamin C
Citation
Leesang T, Lyon P, Pinzone J and Cimmino L (2024) Micronutrient regulation of the DNA methylome. Front. Epigenet. Epigenom. 2:1409355. doi: 10.3389/freae.2024.1409355
Received
29 March 2024
Accepted
15 April 2024
Published
26 April 2024
Volume
2 - 2024
Edited by
Andre J. van Wijnen, University of Vermont, United States
Reviewed by
Hu Wang, Hangzhou Normal University, China
Updates
Copyright
© 2024 Leesang, Lyon, Pinzone and Cimmino.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Luisa Cimmino, luisa.cimmino@med.miami.edu
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.